• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经纤维瘤病 2 型患者大型前庭神经鞘瘤的手术治疗:面神经功能和听力保护的结果。

Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.

机构信息

Neural Reconstruction Department, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing, China.

出版信息

J Neurooncol. 2018 Jun;138(2):417-424. doi: 10.1007/s11060-018-2812-x. Epub 2018 Feb 28.

DOI:10.1007/s11060-018-2812-x
PMID:29492767
Abstract

Surgical treatment of vestibular schwannoma (VS) in patients with neurofibromatosis type 2 (NF2) along with functional preservation of cranial nerves is challenging. The aim of this study was to analyze the outcomes of hearing and facial nerve function in patients with NF2 who underwent large-size VS (> 2 cm) surgery. From 2006 to 2016, one hundred and forty NF2 patients were included with 149 large-size VS resections using retrosigmoid approach. Hearing function was classified according to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) criteria. Preoperative and one-year postoperative facial nerve function were both assessed using the House-Brackmann (H-B) grading scale. A multivariate logistic regression was performed to identify preoperative predictors for facial function outcomes. No operative death we noted. Total tumor removal was achieved in 82.6% of the operated VSs. The anatomical integrity of the facial nerve was preserved in 67.8% of surgeries. Good facial nerve function (H-B Grades I-III) was maintained in 49.6% of patients at 12 months after surgery. Tumor size larger than 3 cm and preoperative facial weakness related with worse outcome of facial nerve function (P < 0.001; for both). Hearing preservation surgeries were attempted in 31 ears. Class B or C hearing according to the AAO-HNS criteria was maintained in 7 ears (22.5%), and measurable hearing was maintained 11 ears (35.5%). It is challenging to maintain hearing and facial nerve function in NF2 patients with large VSs. Early surgical intervention is an appropriate choice to decrease the risk of neurological functions deficit.

摘要

神经纤维瘤病 2 型(NF2)患者的前庭神经鞘瘤(VS)的手术治疗,同时保留颅神经的功能是具有挑战性的。本研究旨在分析 NF2 患者大型 VS(>2cm)手术听力和面神经功能的结果。2006 年至 2016 年,我们共纳入了 149 例采用乙状窦后入路治疗的 NF2 患者,这些患者均存在 149 例大型 VS 切除术。听力功能根据美国耳鼻喉科学-头颈外科学会(AAO-HNS)标准进行分类。术前和术后 1 年面神经功能均采用 House-Brackmann(H-B)分级量表进行评估。采用多变量逻辑回归分析术前预测面神经功能结果的因素。未观察到手术死亡病例。82.6%的手术切除肿瘤完全切除。67.8%的手术保留了面神经解剖结构的完整性。术后 12 个月,49.6%的患者面神经功能良好(H-B 分级 I-III)。肿瘤大小大于 3cm 和术前面神经无力与面神经功能预后较差相关(均 P<0.001)。尝试了 31 例听力保留手术。根据 AAO-HNS 标准,保留 B 级或 C 级听力的有 7 例(22.5%),保留可测量听力的有 11 例(35.5%)。在 NF2 患者中保留大型 VS 的听力和面神经功能具有挑战性。早期手术干预是降低神经功能缺陷风险的适当选择。

相似文献

1
Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.神经纤维瘤病 2 型患者大型前庭神经鞘瘤的手术治疗:面神经功能和听力保护的结果。
J Neurooncol. 2018 Jun;138(2):417-424. doi: 10.1007/s11060-018-2812-x. Epub 2018 Feb 28.
2
Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments.对诊断为2型神经纤维瘤病并发前庭神经鞘瘤患者的显微手术:临床经验与治疗策略
Medicine (Baltimore). 2018 Apr;97(17):e0270. doi: 10.1097/MD.0000000000010270.
3
Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.前庭神经鞘瘤(听神经瘤)的管理:2型神经纤维瘤病患者120例前庭神经鞘瘤切除术后的听觉和面神经功能
Neurosurgery. 1997 Apr;40(4):696-705; discussion 705-6. doi: 10.1097/00006123-199704000-00007.
4
Durability of hearing preservation after microsurgical treatment of vestibular schwannoma using the middle cranial fossa approach.经颅中窝入路显微手术治疗前庭神经鞘瘤后的听力保存持久性。
J Neurosurg. 2013 Jul;119(1):131-8. doi: 10.3171/2013.1.JNS1297. Epub 2013 Feb 15.
5
Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.2型神经纤维瘤病患者前庭神经鞘瘤的外科治疗策略
Neurol Neurochir Pol. 2015;49(5):295-301. doi: 10.1016/j.pjnns.2015.06.008. Epub 2015 Jul 3.
6
Hearing preservation surgery for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients.小儿神经纤维瘤病2型相关前庭神经鞘瘤的听力保留手术
J Neurosurg. 2007 Apr;106(4 Suppl):255-60. doi: 10.3171/ped.2007.106.4.255.
7
Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.中颅窝入路在神经纤维瘤病 2 型中的听力保护作用。
Otol Neurotol. 2011 Dec;32(9):1530-7. doi: 10.1097/MAO.0b013e3182355855.
8
Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.神经纤维瘤病 2 型中前庭神经鞘瘤的手术治疗和听力康复。
Otol Neurotol. 2012 Apr;33(3):466-72. doi: 10.1097/MAO.0b013e318248eaaa.
9
A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas.对接受显微手术切除或立体定向放射外科治疗的小、中型前庭神经鞘瘤患者的临床结局进行配对队列比较。
J Neurosurg. 2016 Dec;125(6):1472-1482. doi: 10.3171/2015.12.JNS151857. Epub 2016 Apr 1.
10
Management strategy of vestibular schwannoma in neurofibromatosis type 2.神经纤维瘤病 2 型中前庭神经鞘瘤的管理策略。
Otol Neurotol. 2011 Sep;32(7):1163-70. doi: 10.1097/MAO.0b013e3182267f17.

引用本文的文献

1
Analysis of the effect of neuroendoscopy-assisted microscopy in the treatment of Large (Koos grade IV) vestibular schwannoma.神经内镜辅助显微镜治疗大型(库斯四级)前庭神经鞘瘤的疗效分析
Front Oncol. 2023 Jan 17;13:1033954. doi: 10.3389/fonc.2023.1033954. eCollection 2023.
2
Qu-Du-San-Jie decoction induces growth inhibition and vascular normalization in NF2-associated vestibular schwannoma.祛毒散结汤诱导神经纤维瘤病2型相关前庭神经鞘瘤生长抑制和血管正常化。
Front Pharmacol. 2022 Aug 19;13:941854. doi: 10.3389/fphar.2022.941854. eCollection 2022.
3
Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2.

本文引用的文献

1
Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.与1型、2型神经纤维瘤病及施万细胞瘤病相关肿瘤的治疗进展
Neuro Oncol. 2016 May;18(5):624-38. doi: 10.1093/neuonc/nov200. Epub 2016 Feb 6.
2
Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.2型神经纤维瘤病患者前庭神经鞘瘤的外科治疗策略
Neurol Neurochir Pol. 2015;49(5):295-301. doi: 10.1016/j.pjnns.2015.06.008. Epub 2015 Jul 3.
3
Vestibular schwannoma between 1 and 3 cm: importance of the tumor size in surgical and functional outcome.
建立用于预测神经纤维瘤病 2 型患者有用听力损失的列线图。
J Neurooncol. 2021 Dec;155(3):373-381. doi: 10.1007/s11060-021-03889-2. Epub 2021 Nov 9.
4
Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.基于生物信息学分析的2型神经纤维瘤病相关前庭神经鞘瘤的基因表达、网络分析及药物发现
J Oncol. 2020 Jul 15;2020:5976465. doi: 10.1155/2020/5976465. eCollection 2020.
5
Therapy of Sporadic and NF2-Related Vestibular Schwannoma.散发性及与神经纤维瘤病2型相关的前庭神经鞘瘤的治疗
Cancers (Basel). 2020 Mar 31;12(4):835. doi: 10.3390/cancers12040835.
6
Surgery of the lateral skull base: a 50-year endeavour.侧颅底手术:50年的探索历程。
Acta Otorhinolaryngol Ital. 2019 Jun;39(SUPPL. 1):S1-S146. doi: 10.14639/0392-100X-suppl.1-39-2019.
7
[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.[18F]氟代胸腺嘧啶和 [18F]氟代脱氧葡萄糖 PET 成像显示摄取并区分神经纤维瘤病 2 相关前庭神经鞘瘤的生长。
Otol Neurotol. 2019 Jul;40(6):826-835. doi: 10.1097/MAO.0000000000002272.
1至3厘米的前庭神经鞘瘤:肿瘤大小对手术及功能预后的重要性
Clin Neurol Neurosurg. 2015 Feb;129:21-6. doi: 10.1016/j.clineuro.2014.11.020. Epub 2014 Dec 4.
4
Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.2型神经纤维瘤病相关多叶状前庭神经鞘瘤的多克隆性证据。
Neuro Oncol. 2015 Apr;17(4):566-73. doi: 10.1093/neuonc/nou317. Epub 2014 Dec 1.
5
Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.伽玛刀治疗2型神经纤维瘤病患者的长期随访研究。
J Neurosurg. 2014 Dec;121 Suppl:143-9. doi: 10.3171/2014.8.GKS141503.
6
Hearing preservation surgery for vestibular schwannomas via the retrosigmoid transmeatal approach: surgical tips.经乙状窦后经外耳道入路行前庭神经鞘瘤的听力保护手术:手术技巧。
Neurosurg Rev. 2014 Jul;37(3):431-44; discussion 444. doi: 10.1007/s10143-014-0543-9. Epub 2014 Apr 22.
7
Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.立体定向放射外科治疗神经纤维瘤病2型相关前庭神经鞘瘤:朝着肿瘤控制和功能结果的剂量优化方向发展。
Neurosurgery. 2014 Mar;74(3):292-300; discussion 300-1. doi: 10.1227/NEU.0000000000000264.
8
Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results.神经纤维瘤病 2 型患者双侧前庭神经鞘瘤的保守治疗:听力和肿瘤生长结果。
Neurosurgery. 2013 Jun;72(6):907-13; discussion 914; quiz 914. doi: 10.1227/NEU.0b013e31828bae28.
9
Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.神经纤维瘤病 2 型相关颅内肿瘤的长期自然史。
J Neurosurg. 2012 Jul;117(1):109-17. doi: 10.3171/2012.3.JNS111649. Epub 2012 Apr 13.
10
Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.神经纤维瘤病 2 型中前庭神经鞘瘤的手术治疗和听力康复。
Otol Neurotol. 2012 Apr;33(3):466-72. doi: 10.1097/MAO.0b013e318248eaaa.